Literature DB >> 31829805

Acute mountain sickness: Do different time courses point to different pathophysiological mechanisms?

Marc M Berger1,2, Mahdi Sareban3, Peter Bärtsch4.   

Abstract

Acute mountain sickness (AMS) is a syndrome of nonspecific symptoms (i.e., headache, anorexia, nausea, vomiting, dizziness, and fatigue) that may develop in nonacclimatized individuals after rapid exposure to altitudes ≥2,500 m. In field studies, mean AMS scores usually peak after the first night at a new altitude. Analyses of the individual time courses of AMS in four studies performed at 3,450 m and 4,559 m revealed that three different patterns are hidden in the above-described overall picture. In 41% of those who developed AMS (i.e., AMS-C score >0.70), symptoms peaked on day 1, in 39%, symptoms were most prominent on day 2, and in 20%, symptoms were most prominent on day 3. We suggest to name the different time courses of AMS type I, type II, and type III, respectively. Here, we hypothesize that the variation of time courses of AMS are caused by different pathophysiological mechanisms. This assumption could explain why no consistent correlations between an overall assessment of AMS and single pathophysiological factors have been found in a large number of studies over the past 50 yr. In this paper, we will briefly review the fundamental mechanisms implicated in the pathophysiology of AMS and discuss how they might contribute to the three different AMS time courses.

Entities:  

Keywords:  AMS; altitude illness; high altitude; hypoxia; kinetic

Mesh:

Year:  2019        PMID: 31829805     DOI: 10.1152/japplphysiol.00305.2019

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  4 in total

1.  Acute mountain sickness and sleep disturbances differentially influence cognition and mood during rapid ascent to 3000 and 4050 m.

Authors:  Peter S Figueiredo; Ingrid V Sils; Janet E Staab; Charles S Fulco; Stephen R Muza; Beth A Beidleman
Journal:  Physiol Rep       Date:  2022-02

2.  High Altitude Cerebral Edema: Improving Treatment Options.

Authors:  Rebecca Zelmanovich; Kevin Pierre; Patrick Felisma; Dwayne Cole; Matthew Goldman; Brandon Lucke-Wold
Journal:  Biologics (Basel)       Date:  2022-03-17

3.  Bioelectrical Impedance Vector Analysis: A Valuable Tool to Monitor Daily Body Hydration Dynamics at Altitude.

Authors:  Ivo B Regli; Rachel Turner; Simon Woyke; Simon Rauch; Hermann Brugger; Hannes Gatterer
Journal:  Int J Environ Res Public Health       Date:  2021-05-20       Impact factor: 3.390

4.  Downregulation of lung miR-203a-3p expression by high-altitude hypoxia enhances VEGF/Notch signaling.

Authors:  Wei Cai; Sanli Liu; Ziquan Liu; Shike Hou; Qi Lv; Huanhuan Cui; Xue Wang; Yuxin Zhang; Haojun Fan; Hui Ding
Journal:  Aging (Albany NY)       Date:  2020-02-29       Impact factor: 5.682

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.